ADMA Biologics (ADMA) shares have skyrocketed 275.7% in a year against the industry's decline of 14.3%. The stock has also outperformed the sector and the S&P 500 during the aforementioned period. ADMA also hit a 52-week high of $23.64 on Nov. 11. The stupendous rally can be attributed to the company's consistently strong quarterly performance and raised guidance. Image Source: Zacks Investment Research ADMA Outperforms Industry, Sector & S&P 500 Asceniv's Performance Fuels ADMA's Growth ADMA Biologics mark ...

Exelixis, Inc. (EXEL) announced that the FDA has notified it about an update to its supplemental new drug application (sNDA) for cabozantinib. The sNDA is seeking approval for cabozantinib for the treatment of adults with previously treated advanced pancreatic neuroendocrine tumors (pNET) and advanced extra-pancreatic (epNET). In November 2024, the FDA notified the company that the sNDA for cabozantinib for the treatment of adults with previously treated advanced pancreatic neuroendocrine tumors (pNET) and ...

A federal judge in Texas on Friday said American Airlines violated federal law by basing investment decisions for its employee retirement plan on environmental, social, and other non-financial factors. The ruling by US District Judge Reed O'Connor appeared to be the first of its kind amid growing backlash by conservatives to an uptick in socially-conscious investing. O'Connor said American had breached its legal duty to make investment decisions based solely on the financial interests of 401(k) plan benefic ...

Meta is reportedly killing its DEI programs — just days after CEO Mark Zuckerberg announced that the tech giant would no longer restrict speech on its popular social media platforms.The Facebook, Instagram and Threads parent said it will no longer take the controversial Diversity, Equity and Inclusion policies into consideration before hiring, training and picking suppliers, Axios reported Friday. According to a memo sent by Janelle Gale, vice president of human resources, the company said it was pivoting a ...

Lake City, Colo., Jan. 10, 2025 (GLOBE NEWSWIRE) -- Beazer Homes and Green Builder Media have partnered to build three show homes, which will be available for tours throughout IBS/KBIS 2025, February 24–28. (The models are located in Henderson, Nev., and are open seven days a week. Hours are from 10 am–6 pm all days except for Monday, which is 1–6 pm.) Come experience in person how production home building has crossed the Rubicon to fabulous market-rate homes built to the country's most respected energy-eff ...

SAN DIEGO, Jan. 10, 2025 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) securities between November 2, 2023 and October 30, 2024, inclusive (the "Class Period"), have until March 10, 2025 to seek appointment as lead plaintiff of the Regeneron class action lawsuit. Captioned Radtke v. Regeneron Pharmaceuticals, Inc., No. 25-cv-00145 (S.D.N.Y.), the Regeneron class action lawsuit charges Regeneron and ce ...

Meta employees spoke out on its internal forum against the tech giant's decision Friday to roll back its DEI program. AD The decision follows sweeping changes made to Meta's content moderation policies announced by Meta chief Mark Zuckerberg on Tuesday. The changes include eliminating third-party fact-checkers in favor of a community notes model similar to Elon Musk's X. As part of the changes to Meta's policy on hateful conduct, the company said it will allow users to say people in the LGBTQ community are ...

On Thursday, Precision BioSciences Inc.’s DTIL partner iECURE reported clinical efficacy and safety data in the first patient dosed with ECUR-506 in the Phase 1/2 OTC-HOPE study.ECUR-506 is iECURE’s in vivo gene insertion program designed to treat neonatal-onset Ornithine Transcarbamylase (OTC) deficiency. It utilizes a PCSK9-specific ARCUS nuclease, licensed from Precision, that enables the insertion of a functional copy of the OTC gene.Ornithine transcarbamylase deficiency is a rare genetic condition that ...

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling over 400 points on Friday. Delta Air Lines, Inc. DAL reported better-than-expected fourth-quarter results and issued 2025 guidance. Delta reported fourth-quarter adj. operating revenue growth of 5.7% year-over-year to $14.437 billion. GAAP operating revenue was $15.56 billion (+9.4% YoY), beating the consensus of $14.212 billion. Adjusted average fuel price was $2.34 per gallon, down from $3.00 from last year's quarter. Ad ...

Video game retailer GameStop Corporation GME is a widely followed stock, but the company hasn’t hosted earnings conference calls in recent years.That could change in 2025 based on a new report and a company job posting.What Happened: The latest quarterly report saw GameStop end the quarter with $4.6 billion in cash. Investors and analysts want to know if the money will be used for acquisitions or investments (i.e., stocks and cryptocurrency).Reporter Charles Gasparino, who is a Fox Business host, suggests t ...